These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38360888)

  • 1. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
    Xiong DD; Xu WQ; He RQ; Dang YW; Chen G; Luo DZ
    Oncol Rep; 2019 Apr; 41(4):2194-2208. PubMed ID: 30816530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches.
    Feng L; Zhu S; Ma J; Huang J; Hou X; Qiu Q; Zhang T; Wan M; Li J
    Front Pharmacol; 2024; 15():1389440. PubMed ID: 38681202
    [No Abstract]   [Full Text] [Related]  

  • 3. Network Pharmacology and Bioinformatics Analysis to Identify the Molecular Targets and its Biological Mechanisms of Sciadopitysin against Glioblastoma.
    Lian H; Xiong Y; Zhao G; Yi M; Wang J; Liu H; Zhou Y
    J Cancer; 2024; 15(12):3675-3683. PubMed ID: 38911393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Prognostic Indicator Based on AU-Rich Elements-Related Genes in Glioblastoma.
    Chen X; Xu Y; Wang M; Ren C
    World Neurosurg; 2023 Jul; 175():e601-e613. PubMed ID: 37030479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFLAM exhibits oncogenic activity and shows promise as a prognostic biomarker and therapeutic target in glioblastoma.
    Li K; Zhu Q; Du S; Zhao Q; Ba D; Zeng X; Peng Q; Cai J; Zhao Y; Jin H; Qi L
    Int Immunopharmacol; 2024 Jul; 138():112625. PubMed ID: 38996666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.
    Zhou HY; Wang YC; Wang T; Wu W; Cao YY; Zhang BC; Wang MD; Mao P
    Oncol Lett; 2024 May; 27(5):206. PubMed ID: 38516683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. System biology approach to identify the novel biomarkers in glioblastoma multiforme tumors by using computational analysis.
    Alqahtani SM; Altharawi A; Alabbas A; Ahmad F; Ayaz H; Nawaz A; Rahman S; Alossaimi MA
    Front Pharmacol; 2024; 15():1364138. PubMed ID: 38841373
    [No Abstract]   [Full Text] [Related]  

  • 8. POLR2J expression promotes glioblastoma malignancy by regulating oxidative stress and the STAT3 signaling pathway.
    Zheng XL; Li ZD; Luo KZ; Li YL; Liu YH; Shen SY; Shen FY; Li WY; Chen GQ; Zhang C; Zeng LH
    Am J Cancer Res; 2024; 14(5):2037-2054. PubMed ID: 38859843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the Clinical Treatment of Glioblastoma.
    Bhrdwaj A; Abdalla M; Pande A; Madhavi M; Chopra I; Soni L; Vijayakumar N; Panwar U; Khan MA; Prajapati L; Gujrati D; Belapurkar P; Albogami S; Hussain T; Selvaraj C; Nayarisseri A; Singh SK
    Appl Biochem Biotechnol; 2023 Aug; 195(8):5094-5119. PubMed ID: 36976507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic computational analysis of the endosomal recycling pathway in glioblastoma.
    Joyce LJ; Lindsay AJ
    Biochem Biophys Rep; 2024 Jul; 38():101700. PubMed ID: 38638676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An End-to-end
    Lin KH; Zhu JJ; Smith JA; Kim Y; Jiang X
    IEEE Int Conf Healthc Inform; 2023 Jun; 2023():738-745. PubMed ID: 38516034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Analyses of Brain Tumor Patients' Multiomic Data Reveals Pharmacological Opportunities to Alter Cell State Transitions.
    Bumbaca B; Birtwistle MR; Gallo JM
    bioRxiv; 2024 May; ():. PubMed ID: 38766170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Analyses of Brain Tumor Patients' Multiomic Data Reveals Pharmacological Opportunities to Alter Cell State Transitions.
    Bumbaca B; Birtwistle MR; Gallo JM
    Res Sq; 2024 May; ():. PubMed ID: 38826227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the therapeutic mechanisms and prognostic targets of Biochanin A in glioblastoma via integrated computational analysis and in vitro experiments.
    Ge W; Yuan G; Wang D; Dong L
    Sci Rep; 2024 Feb; 14(1):3783. PubMed ID: 38360888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods.
    Xia Z; Gao P; Chen Y; Shu L; Ye L; Cheng H; Dai X; Hu Y; Wang Z
    Transl Cancer Res; 2022 May; 11(5):1386-1405. PubMed ID: 35706800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation.
    Ma YQ; Zhang M; Sun ZH; Tang HY; Wang Y; Liu JX; Zhang ZX; Wang C
    World J Gastrointest Oncol; 2024 Feb; 16(2):493-513. PubMed ID: 38425392
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.